ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.665
      -0.14%
      Bitcoin
      65,184.34
      0.07%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Oncorus Inc (ONCR)

      7. Oncorus Inc (ONCR) News

      ONCR

      Oncorus (ONCR)

      Oncorus Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ONCR
      DateTimeSourceHeadlineSymbolCompany
      05/04/20224:33PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ONCROncorus Inc
      05/04/20227:16AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONCROncorus Inc
      05/04/20227:00AMGlobeNewswire Inc.Oncorus Reports First Quarter 2022 Financial Results and Provides Business UpdatesNASDAQ:ONCROncorus Inc
      04/08/20221:00PMGlobeNewswire Inc.Oncorus Presents Preclinical Data on ONCR-021 and ONCR-788 Supporting Selectively Self-Amplifying vRNA Immunotherapy Platform at AACR Annual MeetingNASDAQ:ONCROncorus Inc
      04/05/20227:11AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONCROncorus Inc
      04/05/20227:00AMGlobeNewswire Inc.Oncorus Announces Debt Capital Facility with K2 HealthVentures with $20 Million Funded at Closing, Relocation of Corporate Headquarters and Extension of Cash RunwayNASDAQ:ONCROncorus Inc
      03/21/20227:00AMGlobeNewswire Inc.Oncorus to Present at the Maxim Group 2022 Virtual Growth ConferenceNASDAQ:ONCROncorus Inc
      03/18/20224:25PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONCROncorus Inc
      03/10/20227:00AMGlobeNewswire Inc.Oncorus to Present at the Oppenheimer 32nd Annual Healthcare ConferenceNASDAQ:ONCROncorus Inc
      03/09/20224:28PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ONCROncorus Inc
      03/09/20224:20PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:ONCROncorus Inc
      03/09/20227:00AMGlobeNewswire Inc.Oncorus Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business UpdatesNASDAQ:ONCROncorus Inc
      03/02/20224:47PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONCROncorus Inc
      03/02/20224:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONCROncorus Inc
      03/02/20224:33PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONCROncorus Inc
      02/22/20228:00AMGlobeNewswire Inc.Oncorus Announces Promotion of John Goldberg, M.D. to Chief Medical OfficerNASDAQ:ONCROncorus Inc
      02/15/20226:10AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ONCROncorus Inc
      02/11/20221:51PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ONCROncorus Inc
      02/04/20224:20PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ONCROncorus Inc
      01/26/20224:53PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONCROncorus Inc
      01/10/20228:18AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONCROncorus Inc
      01/03/20227:00AMGlobeNewswire Inc.Oncorus to Present at the H.C. Wainwright BioConnect Virtual ConferenceNASDAQ:ONCROncorus Inc
      12/02/20214:15PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ONCROncorus Inc
      11/23/20217:00AMGlobeNewswire Inc.Oncorus to Present at Upcoming Investor ConferencesNASDAQ:ONCROncorus Inc
      11/22/20216:31AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONCROncorus Inc
      11/17/20217:00AMGlobeNewswire Inc.Oncorus to Present at the Jefferies London Healthcare ConferenceNASDAQ:ONCROncorus Inc
      11/15/20216:43AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ONCROncorus Inc
      11/12/20217:46AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONCROncorus Inc
      11/12/20217:00AMGlobeNewswire Inc.Oncorus Reports Initial Safety, Tolerability, Immune Activation and Positive Clinical Response Data from its Ongoing Phase 1 Clinical Study of ONCR-177, its Lead Viral Immunotherapy Candidate, at SITC 2021NASDAQ:ONCROncorus Inc
      11/11/20217:00AMGlobeNewswire Inc.Oncorus Announces Exclusive Licensing Agreement with Gaeta Therapeutics Ltd. for Use of Locally Delivered Interleukin-12 (IL-12) via Oncolytic Viral Expression in Combination with Immune Checkpoint InhibitorsNASDAQ:ONCROncorus Inc
       Showing the most relevant articles for your search:NASDAQ:ONCR